The management of thoracic endometriosis follows similar principles to pelvic endometriosis, focusing on suppressing ovarian estrogen production to control symptoms through medications like GnRH agonists, which are typically used for a maximum of six to 12 months, danazol as a third-line option, and progestins [20,21]. Here, GNRH1 is linked to endometriosis.